Evidence map›Paper›PMID 26743626›Full record

ReviewParasitology2016

Plasmodium malaria and antimalarial antibodies in the first year of life.

Katherine R Dobbs, Arlene E Dent

Open access · hybridAbstract readReview
In one paragraph

Review in Parasitology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed
11.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 103 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Epidemiology of Plasmodium spp. Detection Among Acute Febrile Illness Patients in Two Regions of Nigeria.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. TargetingiScience · 2024
    Article
  18. Antiplasmodial Activity of ProbioticJournal of tropical medicine · 2024
    Article
  19. Article
  20. Review

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Katherine R DobbsDivision of Pediatric Infectious Diseases, Department of Pediatrics,Rainbow Babies and Children's Hospital,Cleveland, OH,USA.
Arlene E DentDivision of Pediatric Infectious Diseases, Department of Pediatrics,Rainbow Babies and Children's Hospital,Cleveland, OH,USA.
Case Western Reserve University · USRainbow Babies & Children's Hospital · US

Funding

B cell immunity in HIV exposed uninfected infants in KenyaR01AI098511 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI DENT, ARLENE · 2012 to 2015
$2.5M
NIAID NIH HHS AI098511
6 · The paper itself

Abstract

Malaria is one of the most serious infectious diseases with most of the severe disease caused by Plasmodium falciparum (Pf). Naturally acquired immunity develops over time after repeated infections and the development of antimalarial antibodies is thought to play a crucial role. Neonates and young infants are relatively protected from symptomatic malaria through mechanisms that are poorly understood. The prevailing paradigm is that maternal antimalarial antibodies transferred to the fetus in the last trimester of pregnancy protect the infant from early infections. These antimalarial antibodies wane by approximately 6 months of age leaving the infant vulnerable to malaria, however direct evidence supporting this epidemiologically based paradigm is lacking. As infants are the target population for future malaria vaccines, understanding how they begin to develop immunity to malaria and the gaps in their responses is key. This review summarizes the antimalarial antibody responses detected in infants and how they change over time. We focus primarily on Pf antibody responses and will briefly mention Plasmodium vivax responses in infants.

Indexed as

Antibodies, ProtozoanAntibody FormationFemaleHumansInfantInfant, NewbornMalaria, FalciparumMalaria, VivaxPregnancyAntibodies, ProtozoanantibodiesInfantmalariapregnancy-associated malaria

Identifiers

PMID26743626
PMCPMC4825094
OpenAlexW2222378755

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.